Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ANGPTL6 ELISA Kit

Human ANGPTL6 ELISA Kit Colorimetric assay for quantification of Human ANGPTL6.
Catalog No. ABIN5564189

Quick Overview for ANGPTL6 ELISA Kit (ABIN5564189)

Target

See all ANGPTL6 ELISA Kits
ANGPTL6 (Angiopoietin-Like 6 (ANGPTL6))

Reactivity

  • 1
  • 1
  • 1
  • 1
Human

Detection Method

Colorimetric

Method Type

Sandwich ELISA

Detection Range

1.56-100 ng/mL

Application

ELISA

Sample Type

Cell Culture Supernatant, Plasma, Serum
  • Minimum Detection Limit

    1.56 ng/mL

    Analytical Method

    Quantitative

    Specificity

    Detects human ANGPTL6.

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Does not cross-react with human ANGPTL3, human ANGPTL4 or human ANGPTL7.

    Sensitivity

    1.2 ng/mL

    Characteristics

    ANGPTL6 (human) ELISA Kit
  • Plate

    Pre-coated

    Restrictions

    For Research Use only
  • Storage

    4 °C

    Storage Comment

    Short Term Storage: +4°C
    Long Term Storage: +4°C
  • Target See all ANGPTL6 ELISA Kits

    ANGPTL6 (Angiopoietin-Like 6 (ANGPTL6))

    Alternative Name

    ANGPTL6

    Background

    Seven proteins containing an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain, both characteristics of angiopoietins, have been identified and therefore designated angiopoietin-like proteins 1-7 (ANGPTL 1-7). ANGPTL3 and ANGPTL6 (Angiopoietin-related growth factor, AGF), among others, function to regulate angiogenesis and also appear to directly regulate lipid, glucose and energy metabolism. The serum levels of ANGPTL6 are significantly increased in obese humans, patients with type 2 diabetes mellitus (T2DM) and in metabolic syndrome. Therefore, ANGPTL6 may be a novel biomarker for metabolic diseases and may provide a novel therapeutic approach to counteract obesity, T2DM and insulin resistance.

    UniProt

    Q8NI99

    Pathways

    Regulation of Actin Filament Polymerization
You are here:
Chat with us!